THERABIOME LLC has a total of 29 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2013. It filed its patents most often in Australia, Canada and United States. Its main competitors in its focus markets pharmaceuticals and environmental technology are INFIRST HEALTHCARE LTD, GEROLYMATOS P N SA and NUTRITION 21 INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 6 | |
#2 | Canada | 6 | |
#3 | United States | 5 | |
#4 | China | 3 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | Japan | 3 | |
#7 | Hong Kong | 2 | |
#8 | Brazil | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Kabadi Mohan | 25 |
#2 | Schentag Jerome J | 18 |
#3 | Schentag Jerome | 6 |
#4 | Jerome J Schentag | 5 |
#5 | Mohan Kabadi | 4 |
Publication | Filing date | Title |
---|---|---|
CA3013541A1 | Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents | |
AU2013240289A1 | Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix |